ISOVUE 250 is a Intravascular Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Bipso Gmbh. The primary component is Iopamidol.
| Product ID | 76381-317_31076157-8a24-15d8-2f7d-343ddf017bff |
| NDC | 76381-317 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ISOVUE 250 |
| Generic Name | Iopamidol |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVASCULAR |
| Marketing Start Date | 1994-10-12 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020327 |
| Labeler Name | BIPSO GmbH |
| Substance Name | IOPAMIDOL |
| Active Ingredient Strength | 510 mg/mL |
| Pharm Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 1985-12-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Ingredient | Strength |
|---|---|
| IOPAMIDOL | 510 mg/mL |
| SPL SET ID: | 764f5085-7ee8-fdba-2c5b-ae6721014a94 |
| Manufacturer | |
| UNII |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 76381-317 | ISOVUE 250 | ISOVUE 250 |
| 0270-1314 | ISOVUE | IOPAMIDOL |
| 0270-1315 | ISOVUE | IOPAMIDOL |
| 0270-1316 | ISOVUE | IOPAMIDOL |
| 0270-1317 | ISOVUE | IOPAMIDOL |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ISOVUE 85423219 4243227 Dead/Cancelled |
Centrix, Inc. 2011-09-15 |
![]() ISOVUE 75239760 2132582 Dead/Cancelled |
BRACCO DIAGNOSTICS, INC. 1997-02-07 |
![]() ISOVUE 73299442 1237972 Live/Registered |
E. R. Squibb & Sons, Inc. 1981-02-25 |